Centre yet to decide trade margin of expensive drugs despite providing assurance in 2016

Parliamentary panel expresses displeasure over Union Ministry of Chemicals and Fertilizers not fulfilling promise to cap trade profits of …

Boost to pharma production: Africa inches closer to setting up own drug regulator as member states ratify treaty

Agency will ensure drug manufacturers get approval from all African Union member states without a lengthy bureaucratic process

Drug research for children lags behind that for adults; WHO steps in to change it

Bacterial infections, such as pneumonia, neonatal sepsis, and gastrointestinal infections, are the leading causes of death among children worldwide

After cough-syrup, now eye drops: India-made solution causes 1 death, several infections in US

This could be particularly damning for India’s drug regulatory system since it is coming on the heels of cough-syrup-associated deaths in …

‘Immediate action’ needed on sub-standard drugs causing deaths: WHO

At least 300 deaths reported so far in The Gambia, Uzbekistan and Indonesia, most children

WHO alert on ‘sub-standard’ cough syrups made by Noida firm

Alert aginst Ambronol and DOK-1 Max syrups after deaths of children in Uzbekistan

WHO sounds alarm on India-made cough syrups linked to children’s death in The Gambia 

Consuming the products leads to ‘active kidney injuries’ in children, said WHO director-general

Rajasthan’s Right To Health Bill lacks teeth, say experts

Implementation timeframe, process missing from document

Drought impact: Acute malnutrition among children rises 40% in Somalia & Somaliland

Families in Somalia taking extreme measures to survive

Lessons learnt tackling COVID-19 can be used in global AMR response: Report

Increased investment, availability and accessibility of health infrastructure and global cooperation key to tackling AMR, it says 

Accident at Sainor unit in Vizag more proof of companies bypassing rules

Life-saving equipments were absent on-site though the company had approvals to show they were present

COVID-19: Patanjali drugs get go-ahead from govt but key questions unanswered

AYUSH ministry says drugs only for immunity, Patanjali claims patients’ recovery

Many links missing in Patanjali’s claims of COVID-19 drugs

AYUSH ministry halts sales but experts question other government agencies too  

COVID-19 underlines medicine interdependency, which is not good: Experts

Countries must come out of global value chain and become self-dependent, they said

Kendriya Bhandar to open outlets in more states

More than 60-year-old cooperative commits to Gandhian values to stay relevant

RCEP deal to make investors stronger, people weaker, says trade group

The deal will affect access to medicines and seeds by raising the standards of intellectual property rights, claims Forum of Trade Justice

Indian pharma firms receive 34% of FDA warnings this year

These warnings were for misbranding, selling unapproved medicines and violating Current Good Management Practices

Child cancer drugs neither available nor accessible to the poor in Delhi

A study reveals that a lowest-paid government employee will have to spend 55 days’ wages to get a child treated for Hodgkin's lymphoma and …

US sound and fury over drug prices

The US Senate is outraged by the rapacious pricing policy of drug firms but will it act to reform the system?

India, the antibiotic capital of the world

Antibiotics are often used to treat diarrhoea and upper respiratory tract infections, which can be reduced by improving sanitation and personal …

Online drug sale ban: Is there a need to regulate e-pharmacies?

Following an interim ban on online sale of medicines, many questions have been raised on the need for checks and balances

Beware of Japan's trade ambitions

Japan is pushing for higher levels of intellectual property protection that will cut access to affordable medicines

Millions to die from superbug infections: report

2.4 million people could die from superbugs by 2050 if urgent action is not taken to stop antimicrobial resistance, says a report by the …

Patients pay for high margins of pharma firms

Patients in India end up paying more for medicines and all kinds of treatment as prevailing conditions do not allow the market to function …

Can activism check Big Pharma’s profit motives?

As prices of life-saving drugs skyrocket, people from diverse fields are getting together to fight Big Pharma